Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 419,860,300
  • Market Capitalization, $K 419,860
  • Shares Outstanding, K 3,197
  • 60-Month Beta 1.17
  • Price/Book N/A
  • Price/Earnings ttm 25.69
  • Annual Dividend & Yield 5.55 (4.25%)
  • Most Recent Dividend 5.551 on 12/20/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
123.69 +5.38%
on 03/08/19
132.80 -1.84%
on 03/04/19
+1.90 (+1.48%)
since 02/19/19
3-Month
103.25 +26.25%
on 12/24/18
132.80 -1.84%
on 03/04/19
+19.50 (+17.59%)
since 12/19/18
52-Week
103.25 +26.25%
on 12/24/18
136.84 -4.74%
on 10/01/18
+6.72 (+5.44%)
since 03/19/18

Most Recent Stories

More News
Top-Ranked ETF Winners in Dow's Longest Rally in 24 Years

While there are winners in many corners of the space, some ETFs have crushed the Dow Jones by wide margins in three months.

IGN : 56.01 (-0.52%)
XWEB : 89.46 (-0.22%)
PSJ : 91.30 (+0.68%)
QTEC : 82.64 (+0.81%)
PXMG : 56.30 (+0.11%)
XAR : 91.73 (-0.30%)
IGV : 210.48 (+0.58%)
BBH : 130.50 (+0.03%)
FXL : 64.38 (+0.75%)
XSW : 94.01 (+0.31%)
Top-Ranked ETF Winners in Dow's Longest Rally in 24 Years

While there are winners in many corners of the space, some ETFs have crushed the Dow Jones by wide margins in three months.

IGN : 56.01 (-0.52%)
XWEB : 89.46 (-0.22%)
PSJ : 91.30 (+0.68%)
QTEC : 82.64 (+0.81%)
PXMG : 56.30 (+0.11%)
XAR : 91.73 (-0.30%)
IGV : 210.48 (+0.58%)
BBH : 130.50 (+0.03%)
FXL : 64.38 (+0.75%)
XSW : 94.01 (+0.31%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 113.85 (-0.06%)
FBT : 151.26 (+0.05%)
BBH : 130.50 (+0.03%)
GILD : 65.49 (+0.72%)
AMGN : 191.49 (+0.09%)
BIIB : 323.76 (-0.58%)
ALXN : 132.94 (-0.43%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 113.85 (-0.06%)
FBT : 151.26 (+0.05%)
BBH : 130.50 (+0.03%)
GILD : 65.49 (+0.72%)
AMGN : 191.49 (+0.09%)
BIIB : 323.76 (-0.58%)
ALXN : 132.94 (-0.43%)
What's Behind the Biotech ETF Rally to Start 2019?

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

IBB : 113.85 (-0.06%)
IVV : 285.54 (+0.05%)
BBH : 130.50 (+0.03%)
ABBV : 80.82 (+0.21%)
BMY : 49.60 (-0.52%)
BTEC : 35.46 (+0.48%)
BBP : 45.45 (-0.13%)
AZN : 42.87 (+0.68%)
LLY : 126.59 (+1.08%)
FBT : 151.26 (+0.05%)
CLVS : 26.28 (-4.37%)
GILD : 65.49 (+0.72%)
GSK : 40.45 (-0.10%)
BIIB : 323.76 (-0.58%)
What's Behind the Biotech ETF Rally to Start 2019?

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

IBB : 113.85 (-0.06%)
IVV : 285.54 (+0.05%)
BBH : 130.50 (+0.03%)
ABBV : 80.82 (+0.21%)
BMY : 49.60 (-0.52%)
BTEC : 35.46 (+0.48%)
BBP : 45.45 (-0.13%)
AZN : 42.87 (+0.68%)
LLY : 126.59 (+1.08%)
FBT : 151.26 (+0.05%)
CLVS : 26.28 (-4.37%)
GILD : 65.49 (+0.72%)
GSK : 40.45 (-0.10%)
BIIB : 323.76 (-0.58%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 89.07 (+1.23%)
BLUE : 156.10 (-0.04%)
IHE : 155.31 (+0.90%)
PJP : 66.88 (+0.86%)
IBB : 113.85 (-0.06%)
BBH : 130.50 (+0.03%)
IEIH : 26.35 (+0.30%)
BMY : 49.60 (-0.52%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 89.07 (+1.23%)
BLUE : 156.10 (-0.04%)
IHE : 155.31 (+0.90%)
PJP : 66.88 (+0.86%)
IBB : 113.85 (-0.06%)
BBH : 130.50 (+0.03%)
IEIH : 26.35 (+0.30%)
BMY : 49.60 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BBH with:

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

2nd Resistance Point 132.42
1st Resistance Point 131.44
Last Price 130.50
1st Support Level 129.64
2nd Support Level 128.82

See More

52-Week High 136.84
Last Price 130.50
Fibonacci 61.8% 124.01
Fibonacci 50% 120.04
Fibonacci 38.2% 116.08
52-Week Low 103.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar